Contents

Search


screening for cardiovascular disease

Also see cardiovascular risk factor Indications: - screening for AAA*, PAD*, high BP* reduces mortality [2] * screening for abdominal aortic aneurysm (AAA) * screening for peripheral arterial disease (PAD) * screening for hypertension (high BP) Contraindications: - screening general population for cardiovascular risk factors does not improve 10 year risk of ischemic heart disease, stroke, or overall mortality [1] - screening low risk patients with electrocardiogram (ECG) [3]* - no benefit for screening men age 65-74 years [4] * insufficent evidence to recommend for or against screening intermediate or high-risk patients with ECG [3]

Related

cardiovascular disease (CVD) cardiovascular risk factor

Specific

screening for hypertension screening for ischemic heart disease

General

screening

References

  1. Jorgensen T et al Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;348:g3617 PMID: 24912589 http://www.bmj.com/content/348/bmj.g3617 - Gotzsche P General health checks don't work BMJ 2014;348:g3680 PMID: 24912801 http://www.bmj.com/content/348/bmj.g3680
  2. Busko M 'Triple' Screening for AAA, PAD, High BP Reduces Mortality Medscape - Aug 31, 2017. Coverage from the European Society of Cardiology (ESC) Congress 2017 http://www.medscape.com/viewarticle/885058
  3. Bhatia RS, Dorian P. Screening for Cardiovascular Disease Risk With Electrocardiography. JAMA Intern Med. Published online June 12, 2018 Bhatia RS, Dorian P. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2683617 - US Preventive Services Task Force Screening for Cardiovascular Disease Risk With Electrocardiography. US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(22):2308-2314 PMID: 29896632 https://jamanetwork.com/journals/jama/fullarticle/2684613 - Jonas DE, Reddy S, Middleton JC et al Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography. Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018;319(22):2315-2328 PMID: 29896633 https://jamanetwork.com/journals/jama/fullarticle/2684614 - Myerburg RJ The Screening ECG and Cardiac Risks. JAMA. 2018;319(22):2277-2279. PMID: 29896615 https://jamanetwork.com/journals/jama/fullarticle/2684593
  4. Lindholt JS et al. Five-year outcomes of the Danish Cardiovascular Screening (DANCAVAS) trial. N Engl J Med 2022 Aug 27; [e-pub] PMID: 36027560 https://www.nejm.org/doi/10.1056/NEJMoa2208681

Components

screening for abdominal aortic aneurysm (AAA) screening for hypertension screening for peripheral arterial disease